Slide background
Slide background




Guidance on the determination of potential health effects of nanomaterials used in medical devices

ID 1982 | | Visite: 4664 | Documenti Marcatura CE UEPermalink: https://www.certifico.com/id/1982

Guidance on the determination of potential health effects of nanomaterials used in medical devices

This Guidance addresses the use of nanomaterials in medical devices and provides information for risk assessors regarding specific aspects that need to be considered in the safety evaluation of nanomaterials.

According to the EU Recommendation for the definition of a nanomaterial (Commission Recommendation 2011/696/EU, EC 2011) any particulate substance with at least one dimension in the size range between 1 and 100 nm is considered a nanomaterial.

These particles (nanoparticles) exhibit specific characteristics that differ from the characteristics of larger sized particles with the same chemical composition.

The use of nanomaterials in medical devices poses a challenge for the safety evaluation and risk assessment of these medical devices as the specific character of the nanomaterial used should be taken into consideration.

The various aspects of safety evaluation and risk assessment of medical devices containing nanomaterials are addressed in this Guidance.

The use of nanomaterials in medical devices can vary considerably. Examples are the use of free nanomaterials being a medical device and administered to the patient as such (e.g. iron oxide or gold nanomaterials for heat therapy against cancer), free nanomaterials in a paste-like formulation (e.g. dental filling composites), free nanomaterials added to a medical device (e.g. nanosilver as antibacterial agent in wound dressings), fixed nanomaterials forming a coating on implants to increase biocompatibility (e.g. nano-hydroxyapatite) or to prevent infection (e.g. nano-silver), or embedded nanomaterials to strengthen biomaterials (e.g. carbon nanotubes in a catheter wall). In all these cases the potential exposure to the nanomaterials should be considered.

It is additionally recognised that wear-and-tear of medical devices may result in the generation of nanosized particles even when the medical device itself does not contain nanomaterials.

Guidance is provided on physico-chemical characterisation of nanomaterials, the determination of hazards associated with the use of nanomaterials, and risk assessment for the use of nanomaterials in medical devices.

The safety evaluation of the nanomaterials used in medical devices is discussed in the context of the general framework for biological evaluation of medical devices as described in the ISO 10993-1:2009 standard.

Therefore, the risk assessment should be performed taking into consideration the type of device, the type of tissue contact, and the contact duration, thus identifying the specific exposure scenario.

This Guidance provides information to assist with safety evaluation and risk assessment on the use of nanomaterials in medical devices that should be considered in conjunction with the ISO 10993-1:2009 standard.

The Guidance highlights the need for special considerations in relation to the safety evaluation of nanomaterials, in view of the possible distinct properties, interactions, and/or effects that may differ from conventional forms of the same materials. For some assays evaluating potential hazards of nanomaterials adaptation of existing assays may be necessary. In addition, it is also possible to apply this Guidance for the safety evaluation and risk assessment of particles with a size larger than 100 nm.

European Commission 2015

Tags: Marcatura CE Direttiva Dispositivi medici

Ultimi archiviati Marcatura CE

Ott 29, 2024 112

Decisione (UE) 2024/2779

Decisione (UE) 2024/2779 ID 22821 | 29.10.2024 Decisione (UE) 2024/2779 della Commissione, del 24 ottobre 2024, che istituisce il gruppo di esperti sulla progettazione ecocompatibile dei prodotti sostenibili e sull’etichettatura energetica (forum sulla progettazione ecocompatibile) (GU L 2024/2779… Leggi tutto
Ott 22, 2024 209

Regolamento di esecuzione (UE) 2024/994

Regolamento di esecuzione (UE) 2024/994 / Ecodesign banca dati dei prodotti ID 22773 | 22.10.2024 Regolamento di esecuzione (UE) 2024/994 della Commissione del 2 aprile 2024 recante i dettagli operativi della banca dati dei prodotti istituita a norma del regolamento (UE) 2017/1369 del Parlamento… Leggi tutto
Set 21, 2024 2463

Decreto 17 settembre 2024 n. 133

Decreto 17 settembre 2024 n. 133 ID 22594 | 21.09.2024 Decreto 17 settembre 2024 n. 133 - Regolamento di modifica al decreto 29 luglio 2008, n. 146 concernente il regolamento di attuazione dell'articolo 65 del decreto legislativo 18 luglio 2005, n. 171, recante il codice della nautica da diporto.… Leggi tutto

Più letti Marcatura CE

Nov 08, 2024 117329

Regolamento Prodotti da Costruzione (UE) 305/2011 - CPR

Regolamento CPR (UE) 305/2011 Regolamento (UE) N. 305/2011 del Parlamento Europeo e del Consiglio del 9 marzo 2011 che fissa condizioni armonizzate per la commercializzazione dei prodotti da costruzione e che abroga la direttiva 89/106/CEE del Consiglio (Testo rilevante ai fini del SEE) (GU L 88/10… Leggi tutto